Robert Silver, MD
Otolaryngology · Edina, MNNPI 1295879567
Payments from drug & device makers
Across 37 payments — averaging $21.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$143
- Aerin Medical Inc.$129
- Phadia US Inc.$99
- Regeneron Healthcare Solutions, Inc.$85
- Intersect ENT, Inc.$67
- Preceptis Medical, Inc.$61
- plus $222 from 8 others
What the payments were for
- Food & beverage$807100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 7 | $143 |
| Aerin Medical Inc. | 4 | $129 |
| Phadia US Inc. | 6 | $99 |
| Regeneron Healthcare Solutions, Inc. | 5 | $85 |
| Intersect ENT, Inc. | 1 | $67 |
| Preceptis Medical, Inc. | 1 | $61 |
| Medtronic | 3 | $61 |
| Optinose US, Inc. | 4 | $47 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
| Sanofi | 1 | $14 |
| Cook Medical LLC | 1 | $11 |
How this compares
$807 in reported general payments places this provider in the 55th percentile of 181 otolaryngology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 93 | $5,073 |
| Dexamethasone Sodium Phosphate | 30 | $1,579 |
| Ofloxacin | 59 | $1,540 |
| Fluticasone Propionate | 39 | $1,049 |
| Famotidine | 54 | $1,029 |
| Cefdinir | 29 | $563 |
| Azelastine Hcl | 23 | $470 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 48 | $318 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 29 | $178 |
| Mupirocin | 30 | $159 |
| Prednisone | 33 | $91 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $55 |
| Cephalexin | 14 | $47 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Edina
- Jeffrey MellaEdina$2K
- Matthew CarlsonRochester$928K
- Abby MeyerMinneapolis$331K
- Theodore TruittSaint Cloud$310K
- George GodingMinneapolis$193K
- Shelagh CoferRochester$169K
- Samuel LevineMinneapolis$151K
- Brian NeffRochester$64K
- Ronald HansonSaint Cloud$60K
- Christopher HiltonSaint Paul$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.